These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 17123400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R, Moir C, Pruthi RK, Stavlo PL, Schmidt KA, Rodriguez V.
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia.
    Ranta S, Kalajoki-Helmiö T, Pouttu J, Mäkipernaa A.
    Haemophilia; 2012 Jul; 18(4):521-6. PubMed ID: 22176603
    [Abstract] [Full Text] [Related]

  • 7. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH, Furmedge J, Ekert J, Crameri J, Curtis N, Barnes C.
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [Abstract] [Full Text] [Related]

  • 8. Central venous access devices in children with hemophilia: an update.
    Blanchette VS, Al-Musa A, Stain AM, Ingram J, Fille RM.
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S11-4. PubMed ID: 9351530
    [Abstract] [Full Text] [Related]

  • 9. The use of central venous catheters in haemophilia patients.
    Izzi G, Franchini M, Bonetti L, Tagliaferri A.
    Haemophilia; 2010 Jan; 16 Suppl 1():29-31. PubMed ID: 20059567
    [Abstract] [Full Text] [Related]

  • 10. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
    Mancuso ME, Mannucci PM, Sartori A, Agliardi A, Santagostino E.
    Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
    [Abstract] [Full Text] [Related]

  • 11. Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy.
    Hacker MR, Page JH, Shapiro AD, Rich-Edwards JW, Manco-Johnson MJ.
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):458-64. PubMed ID: 17609623
    [Abstract] [Full Text] [Related]

  • 12. Central venous access devices in patients with hemophilia.
    Valentino LA, Kapoor M.
    Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
    [Abstract] [Full Text] [Related]

  • 13. Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.
    Rajpurkar M, Boldt-Macdonald K, McLenon R, Callaghan MU, Chitlur M, Lusher JM, Becker C.
    Haemophilia; 2009 Nov; 15(6):1267-71. PubMed ID: 19659937
    [Abstract] [Full Text] [Related]

  • 14. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
    Langley AR, Stain AM, Chan A, McLimont M, Chait S, Wu J, Poon MC, Card R, Israels SJ, Laferriere N, Klaassen RJ, Rivard GE, Cloutier S, Hawes S, Feldman B, Blanchette V.
    Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
    [Abstract] [Full Text] [Related]

  • 15. Venous access in the management of hemophilia.
    Valentino LA, Kawji M, Grygotis M.
    Blood Rev; 2011 Jan; 25(1):11-5. PubMed ID: 21030121
    [Abstract] [Full Text] [Related]

  • 16. Central venous access catheters in children with haemophilia.
    Blanchette VS, al-Musa A, Stain AM, Filler RM, Ingram J.
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S39-44. PubMed ID: 8735796
    [Abstract] [Full Text] [Related]

  • 17. The risk associated with indwelling catheters in children with haemophilia.
    Ljung R.
    Br J Haematol; 2007 Sep; 138(5):580-6. PubMed ID: 17686052
    [Abstract] [Full Text] [Related]

  • 18. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study.
    Rodriguez V, Mancuso ME, Warad D, Hay CR, DiMichele DM, Valentino L, Kenet G, Kulkarni R.
    Haemophilia; 2015 Sep; 21(5):e369-74. PubMed ID: 26178581
    [Abstract] [Full Text] [Related]

  • 19. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL, Bodner LJ, Ettinger LJ, Siegel RL, Gribbin C, Asch J, Drachtman RA.
    Cardiovasc Intervent Radiol; 2001 Sep; 24(6):395-9. PubMed ID: 11907746
    [Abstract] [Full Text] [Related]

  • 20. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R.
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.